Cargando…

The 5-Lipoxygenase Inhibitor Zileuton Protects Pressure Overload-Induced Cardiac Remodeling via Activating PPARα

Zileuton has been demonstrated to be an anti-inflammatory agent due to its well-known ability to inhibit 5-lipoxygenase (5-LOX). However, the effects of zileuton on cardiac remodeling are unclear. In this study, the effects of zileuton on pressure overload-induced cardiac remodeling were investigate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Qing-Qing, Deng, Wei, Xiao, Yang, Chen, Jiao-Jiao, Liu, Chen, Wang, Juan, Guo, Yankai, Duan, Mingxia, Cai, Zhulan, Xie, Saiyang, Yuan, Yuan, Tang, Qizhu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6874937/ https://www.ncbi.nlm.nih.gov/pubmed/31781348 http://dx.doi.org/10.1155/2019/7536803

Ejemplares similares

Andrographolide Protects Against Adverse Cardiac Remodeling After Myocardial Infarction through Enhancing Nrf2 Signaling Pathway
por: Xie, Saiyang, et al.
Publicado: (2020)

Inhibition of 5-lipoxygenase by zileuton in a rat model of myocardial infarction
por: Abueid, Leyla, et al.
Publicado: (2017)

High-mobility group AT-hook 1 promotes cardiac dysfunction in diabetic cardiomyopathy via autophagy inhibition
por: Wu, Qing-Qing, et al.
Publicado: (2020)

Diminished arachidonate 5-lipoxygenase perturbs phase separation and transcriptional response of Runx2 to reverse pathological ventricular remodeling
por: Xie, Saiyang, et al.
Publicado: (2022)

New Zileuton-Hydroxycinnamic Acid Hybrids: Synthesis and Structure-Activity Relationship towards 5-Lipoxygenase Inhibition
por: Chiasson, Audrey Isabel, et al.
Publicado: (2020)

Nucleotide-Binding Oligomerization Domain-Like Receptor 3 Deficiency Attenuated Isoproterenol-Induced Cardiac Fibrosis via Reactive Oxygen Species/High Mobility Group Box 1 Protein Axis
por: Liu, Chen, et al.
Publicado: (2020)

Inhibition of 5-lipoxygenase inhibitor zileuton in high-fat diet-induced nonalcoholic fatty liver disease progression model
por: Ma, Kuifen, et al.
Publicado: (2017)

Zileuton, 5-Lipoxygenase Inhibitor, Acts as a Chemopreventive Agent in Intestinal Polyposis, by Modulating Polyp and Systemic Inflammation
por: Gounaris, Elias, et al.
Publicado: (2015)

Zileuton, a 5-Lipoxygenase Inhibitor, Exerts Anti-Angiogenic Effect by Inducing Apoptosis of HUVEC via BK Channel Activation
por: Lim, Hyun-Joung, et al.
Publicado: (2019)

Zileuton, a 5-Lipoxygenase Inhibitor, Attenuates Haemolysate-Induced BV-2 Cell Activation by Suppressing the MyD88/NF-κB Pathway
por: Su, Hui-Yuan, et al.
Publicado: (2022)

Targeting PPARα in low ambient temperature exposure-induced cardiac dysfunction and remodeling
por: Chen, Xi-Yao, et al.
Publicado: (2021)

A 5-Lipoxygenase Inhibitor, Zileuton, Modulates Host Immune Responses and Improves Lung Function in a Model of Severe Acute Respiratory Syndrome (SARS) Induced by Betacoronavirus
por: Pereira, Rafaela das Dores, et al.
Publicado: (2023)

The Effects of Zileuton and Montelukast in Reperfusion-Induced Arrhythmias in Anesthetized Rats()
por: Gonca, Ersöz
Publicado: (2013)

Achievement of a target dose of bisoprolol may not be a preferred option for attenuating pressure overload-induced cardiac hypertrophy and fibrosis
por: Xiang, Shizhao, et al.
Publicado: (2016)

Postnatal Deletion of Bmal1 in Cardiomyocyte Promotes Pressure Overload Induced Cardiac Remodeling in Mice
por: Liang, Qing, et al.
Publicado: (2022)

PPARα alleviates iron overload‐induced ferroptosis in mouse liver
por: Xing, Guowei, et al.
Publicado: (2022)

Schisandrin B attenuates pressure overload-induced cardiac remodeling in mice by inhibiting the MAPK signaling pathway
por: Ai, Fen, et al.
Publicado: (2019)

Maximum Time of the Effect of Antileukotriene - Zileuton in Treatment of Patients with Bronchial Asthma
por: Morina, Naim, et al.
Publicado: (2016)

Repurposing Zileuton as a Depression Drug Using an AI and In Vitro Approach
por: Kubick, Norwin, et al.
Publicado: (2020)

Activation of Nrf2 by Lithospermic Acid Ameliorates Myocardial Ischemia and Reperfusion Injury by Promoting Phosphorylation of AMP-Activated Protein Kinase α (AMPKα)
por: Zhang, Min, et al.
Publicado: (2021)

Reversal of High dietary fructose-induced PPARα suppression by oral administration of lipoxygenase/cyclooxygenase inhibitors
por: Kelley, Glen L, et al.
Publicado: (2005)

Mitophagy: A Potential Target for Pressure Overload-Induced Cardiac Remodelling
por: Shao, Ruochen, et al.
Publicado: (2022)

OSMR deficiency aggravates pressure overload-induced cardiac hypertrophy by modulating macrophages and OSM/LIFR/STAT3 signalling
por: Feng, Yizhou, et al.
Publicado: (2023)

Metabolic landscape in cardiac aging: insights into molecular biology and therapeutic implications
por: Xie, Saiyang, et al.
Publicado: (2023)

Differential Transcriptome Profile and Exercise Capacity in Cardiac Remodeling by Pressure Overload versus Volume Overload
por: Kim, Kyung-Hee, et al.
Publicado: (2019)

The peroxisome proliferator-activated receptor agonist pioglitazone and 5-lipoxygenase inhibitor zileuton have no effect on lung inflammation in healthy volunteers by positron emission tomography in a single-blind placebo-controlled cohort study
por: Chen, Delphine L., et al.
Publicado: (2018)

Clinical Study of Aspirin and Zileuton on Biomarkers of Tobacco-Related Carcinogenesis in Current Smokers
por: Garland, Linda L., et al.
Publicado: (2022)

Olmesartan attenuates pressure-overload- or post-infarction-induced cardiac remodeling in mice
por: Wang, Qiancheng, et al.
Publicado: (2017)

Biventricular Remodeling in Murine Models of Right Ventricular Pressure Overload
por: Kapur, Navin K., et al.
Publicado: (2013)

Cardiomyocyte ZKSCAN3 regulates remodeling following pressure‐overload
por: Ouyang, Xiaosen, et al.
Publicado: (2023)

Pressure Overload-induced Cardiac Remodeling and Dysfunction in the Absence of Interleukin 6 in Mice
por: Lai, N. Chin, et al.
Publicado: (2012)

IKKi Deficiency Promotes Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis
por: Dai, Jia, et al.
Publicado: (2013)

Zileuton suppresses cholangiocarcinoma cell proliferation and migration through inhibition of the Akt signaling pathway
por: Khophai, Sasikamon, et al.
Publicado: (2018)

A Reduction in ADAM17 Expression Is Involved in the Protective Effect of the PPAR-α Activator Fenofibrate on Pressure Overload-Induced Cardiac Hypertrophy
por: Zeng, Si-Yu, et al.
Publicado: (2018)

Effects of Multikinase inhibitors on pressure overload-induced right ventricular remodelling
por: Kojonazarov, Baktybek, et al.
Publicado: (2013)

Pressure-overload-induced angiotensin-mediated early remodeling in mouse heart
por: Kim, Jeremy H., et al.
Publicado: (2017)

Innate Immune Cells in Pressure Overload-Induced Cardiac Hypertrophy and Remodeling
por: Liu, Xin, et al.
Publicado: (2021)

Inhibition of farnesyl pyrophosphate synthase improves pressure overload induced chronic cardiac remodeling
por: Zhao, Chen-Ze, et al.
Publicado: (2016)

5-Lipoxygenase contributes to PPARγ activation in macrophages in response to apoptotic cells
por: von Knethen, A, et al.
Publicado: (2012)

LCZ696 Ameliorates Oxidative Stress and Pressure Overload-Induced Pathological Cardiac Remodeling by Regulating the Sirt3/MnSOD Pathway
por: Peng, Shi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_eot402j7hougej5f95dasl3bu7